Document is current
Any future updates will be listed below
-
Authors
Jiang, Tingting
Chai, Huihui
Shan, Xuexia
Deng, Erya
Yu, Songyuan
Bo, Xiaowan
Li, Xiaolong
He, Hongfeng
Zhang, Zhengxian
Weng, Ning
Qin, Xiachuan
Fan, Jing
Tang, Xiaoqing
Heng, Wei
Li, Yong
Li, Jiaxin
Zhu, Jinge
Zhang, Huili
Sun, Liping
Peng, Chengzhong https://orcid.org/0000-0003-4886-7466
Yue, Wenwen
Xu, Huixiong
-
Funding
Funding for this research was provided by:
National Natural Science Foundation of China (82272005)
- License Information
-
More Information
Article History
Received: 28 December 2024
Revised: 24 March 2025
Accepted: 19 April 2025
First Online: 23 May 2025
Compliance with ethical standards
:
: The scientific guarantor of this publication is Chengzhong Peng.
: The authors of this manuscript declare no relationships with any companies, whose products or services may be related to the subject matter of the article.
: No complex statistical methods were necessary for this paper.
: Written informed consent was waived by the Institutional Review Board.
: Institutional Review Board approval was not required because the data is secondary data and does not contain any data that can identify an individual.
: One hundred sixty-five sHPT patients were enrolled in a study published in a previous study. Previous studies have focused on the long-term efficacy and safety of RFA for sHPT. In contrast, the present study focused exclusively on complication rates after RFA and associated risk predictors in a large patient cohort encompassing both pHTP and sHPT cases.
:
